Seeking Alpha

David Greene's  Instablog

Trading and investing full time for personal account and consulting with a money manager firm with assets of over $55 Million. Worked on Wall Street for 14 years at two wirehouses and one boutique investment banking firm. Investment discipline includes taking advantage of Wall Street's tendency... More
My blog:
sirf.com
  • Competitive Technologies (NYSE Amex:CTT)--FDA Approved Medical Device Hitting the Revenue Line 0 comments
    Nov 9, 2009 12:02 AM | about stocks: CTT
    CTT is begining to see revenues generated as a result of  the FDA approval of their very promising chronic pain mangement medical device.  The company has already announced orders for 70 units and will recognize revenue for 17 units shipped in the past quarter (ending Oct. 31).

    Five insiders, including the CEO, took advantage of the permitted window for insider purchaes last week and added to their holdings, despite the stock's 80% appreciation YTD.

    CTT is also on the screens of mutual funds and money managers, with 6% of the shares outstanding held by institutions--enough to know that a few investment professionals are aware of CTT, but are clearly not fully invested should CTT exhibit progress in their business plan of expanding the market for their newly approved device.  In other words, there is alot more room for adding to their positions with their holdings representing a very modest 6% now, than if the institutions were holding 60% of the shares O/S.

    CTT's  medical technology involves a non-invasive method for the rapid treatment of intese oncologic and neuropathic pain, including pain resistant to morphine and other traditional pain management drugs. CTT's device is currently in clinical trials for chemotherapy-induced pain and expects to be able to announce the results of the patient trials in the near future. 

    Investos should monitor CTT for future news on sales, increases in institutional ownership and trading volume increases. With only 10.24 Million shares outstanding, any increased exposure to the investment world could result in a dramatic increase in the stock's price as new investors take a position.

    Disclosure: Long CTT

     
    Themes: Medical Device Technology, Medical Technology, Micro-cap; Stocks: CTT
Back To David Greene's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Full index of posts »
Latest Followers
Posts by Ticker
ADLR, AFFX, BDX, CELG, CMN, CTT, DNDN, GILD, GSK, HGSI, IART, IRIX, MLNM, PFE, PGNX, RDNT, SQNM, VVUS, WYE
Posts by Themes
Biopharmaceutical, Biotechnology, Bottom Reversal, Healthcare, Healtthcare, Life Sciences, Medical Device Technology, Medical Devices, Medical Technology, Micro-cap; , Pharmaceuticals
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.